TN2013000026A1 - Use of sigma ligands in opioid - induced hyperalgesia - Google Patents

Use of sigma ligands in opioid - induced hyperalgesia

Info

Publication number
TN2013000026A1
TN2013000026A1 TNP2013000026A TN2013000026A TN2013000026A1 TN 2013000026 A1 TN2013000026 A1 TN 2013000026A1 TN P2013000026 A TNP2013000026 A TN P2013000026A TN 2013000026 A TN2013000026 A TN 2013000026A TN 2013000026 A1 TN2013000026 A1 TN 2013000026A1
Authority
TN
Tunisia
Prior art keywords
opioid
induced hyperalgesia
sigma ligands
sigma
hyperalgesia
Prior art date
Application number
TNP2013000026A
Other languages
English (en)
Inventor
Hernandez Jose Miguel Vela
Daniel Zamanillo-Castanedo
Riera De Conias Margarita Puig
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2011/063286 external-priority patent/WO2012016980A2/fr
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of TN2013000026A1 publication Critical patent/TN2013000026A1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TNP2013000026A 2011-08-02 2013-01-28 Use of sigma ligands in opioid - induced hyperalgesia TN2013000026A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/063286 WO2012016980A2 (fr) 2010-08-03 2011-08-02 Utilisation de ligands sigma dans une hyperalgie induite par des opioïdes

Publications (1)

Publication Number Publication Date
TN2013000026A1 true TN2013000026A1 (en) 2014-06-25

Family

ID=54360737

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000026A TN2013000026A1 (en) 2011-08-02 2013-01-28 Use of sigma ligands in opioid - induced hyperalgesia

Country Status (1)

Country Link
TN (1) TN2013000026A1 (fr)

Similar Documents

Publication Publication Date Title
PH12013500203A1 (en) Use of sigma ligands in opioid-induced hyperalgesia
TN2013000227A1 (en) Use of sigma ligands in bone cancer pain
SG10201903119QA (en) Polypeptide vaccine
TN2013000508A1 (en) Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer
MX356525B (es) Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia.
PH12012501719A1 (en) Compounds for immunoproteasome inhibition
NZ702244A (en) Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
MX2013010969A (es) Ciclopropilaminas como inhibidores de desmetilasa 1 especifica de lisina.
TN2013000460A1 (en) Use of sigma ligands in diabetes type-2 associated pain
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
MX2014014832A (es) Pirrolopirimidona y pirrolopiridona, inhibidores de tanquirasa.
IL217911A0 (en) Sigma ligands for the prevention or treatment of pain induced by chemotherapy
MX2015008813A (es) Composiciones y metodos para contrarrestar la inhibicion del factor xa.
MY178390A (en) Inhibitors of iap
JO3145B1 (ar) مركبات مفيدة لتثبيط chk1
TN2013000283A1 (en) Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents
MX343968B (es) Inhibidor de proteasoma delanzomib para uso en el tratamiento de lupus.
IN2014DN02482A (fr)
MX2013010947A (es) Complejos de galio, composiciones farmacéuticas y métodos de uso.
MX362111B (es) Un metodo para mejorar la funcion hepatica.
MX2014006255A (es) Tratamientos neurologiocos con metaloporfirina.
TN2013000026A1 (en) Use of sigma ligands in opioid - induced hyperalgesia
WO2012158776A3 (fr) Thérapie d'association pour le traitement du cancer
MX350868B (es) Medicamentos y metodos para tratar cancer.
UA65243U (ru) Применение радиоактивного цисплатина как вещества с усиленным противоопухолевым действием